<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 03 Dec 2018 09:15:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</guid>
   <pubDate>Mon, 03 Dec 2018 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19809304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24478717</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25724027</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</guid>
   <pubDate>Mon, 03 Dec 2018 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19809304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24478717</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25724027</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</guid>
   <pubDate>Mon, 03 Dec 2018 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19809304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24478717</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25724027</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</guid>
   <pubDate>Mon, 03 Dec 2018 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19809304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24478717</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25724027</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</guid>
   <pubDate>Mon, 03 Dec 2018 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19809304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24478717</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25724027</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</guid>
   <pubDate>Mon, 03 Dec 2018 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19809304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24478717</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25724027</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html</guid>
   <pubDate>Mon, 03 Dec 2018 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19809304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24478717</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.25724027</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28110669</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Advances ONS-5010 into wet AMD Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html</guid>
   <pubDate>Tue, 06 Nov 2018 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Advances ONS-5010 into wet AMD Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html</guid>
   <pubDate>Tue, 06 Nov 2018 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Advances ONS-5010 into wet AMD Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html</guid>
   <pubDate>Tue, 06 Nov 2018 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Provides Business Update and Reports Third Quarter Financial Results for Fiscal 2018</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html</guid>
   <pubDate>Tue, 14 Aug 2018 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Provides Business Update and Reports Third Quarter Financial Results for Fiscal 2018</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html</guid>
   <pubDate>Tue, 14 Aug 2018 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Provides Business Update and Reports Third Quarter Financial Results for Fiscal 2018</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html</guid>
   <pubDate>Tue, 14 Aug 2018 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics (ONS) Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464825.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:14:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16996876</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16996876</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
  <item>
   <title>Oncobiologics Appoints Lawrence A. Kenyon as President and CEO</title>
   <link>http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Oncobiologics+Appoints+Lawrence+A.+Kenyon+as+President+and+CEO/14464612.html</guid>
   <pubDate>Thu, 02 Aug 2018 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16996876</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ONSIZ</category>
   	  </item>
 </channel>
</rss>
